We are live on ! Find out more
RP

Riverbridge Partners Portfolio holdings

AUM $3.58B
1-Year Est. Return 4.02%
This Fund
S&P 500
This Quarter Est. Return
-0.02%
1 Year Est. Return
+4.02%
3 Year Est. Return
+40.43%
5 Year Est. Return
+44.7%
10 Year Est. Return
+473.33%
AUM
$5.53B
AUM Growth
+$10.1M
Cap. Flow
+$62.9M
Cap. Flow %
1.14%
Top 10 Hldgs %
28.72%
Holding
130
New
4
Increased
67
Reduced
44
Closed
2

Top Sells

Rank Stock Value
1
ATHN
Athenahealth, Inc.
ATHN
+$65.4M
2
CSGP icon
CoStar Group
CSGP
+$41.9M
3
PRGO icon
Perrigo
PRGO
+$26.9M
4
TECH icon
Bio-Techne
TECH
+$20.1M
5
MDT icon
Medtronic
MDT
+$2.56M

Sector Composition

Rank Sector Weight
1 Technology 23.65%
2 Industrials 18.83%
3 Healthcare 15.77%
4 Consumer Discretionary 11.11%
5 Consumer Staples 6.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CPHD
1
DELISTED
Cepheid Inc
CPHD
$251M 4.55%
4,874,713
+82,866
+2% +$4.21M
ULTI
2
DELISTED
Ultimate Software Group Inc
ULTI
$169M 3.06%
1,234,232
+1,386
+0.1% +$217K
PRAA icon
3
PRA Group
PRAA
$684M
$161M 2.92%
2,786,302
+6,726
+0.2% +$361K
RBA icon
4
RB Global
RBA
$21.7B
$154M 2.78%
6,376,926
+206,268
+3% +$4.73M
MD icon
5
Pediatrix Medical
MD
$2.19B
$152M 2.75%
2,449,919
+11,540
+0.5% +$671K
NATI
6
DELISTED
National Instruments Corp
NATI
$144M 2.61%
5,034,085
+68,015
+1% +$2.03M
MMS icon
7
Maximus
MMS
$3.32B
$140M 2.53%
3,113,378
-16,964
-0.5% -$767K
UNFI icon
8
United Natural Foods
UNFI
$3.07B
$139M 2.51%
1,955,543
+18,506
+1% +$1.32M
LOPE icon
9
Grand Canyon Education
LOPE
$4.17B
$138M 2.5%
2,963,436
-42,049
-1% -$1.95M
GNTX icon
10
Gentex
GNTX
$5.12B
$138M 2.5%
8,760,106
+140,258
+2% +$2.24M
CHE icon
11
Chemed
CHE
$7.08B
$138M 2.49%
1,540,743
+11,284
+0.7% +$919K
TRAK
12
DELISTED
DEALERTRACK TECHNOLOGIES, INC. COM STK
TRAK
$127M 2.29%
2,573,821
+17,493
+0.7% +$878K
BECN
13
DELISTED
Beacon Roofing Supply, Inc.
BECN
$124M 2.24%
3,201,216
+64,204
+2% +$2.48M
ROL icon
14
Rollins
ROL
$18.8B
$123M 2.23%
13,780,719
-10,598
-0.1% -$92.5K
ATHN
15
DELISTED
Athenahealth, Inc.
ATHN
$116M 2.1%
723,400
-397,612
-35% -$65.4M
CSGP icon
16
CoStar Group
CSGP
$12.3B
$114M 2.07%
6,110,880
-2,222,520
-27% -$41.9M
NEOG icon
17
Neogen
NEOG
$2.01B
$113M 2.04%
6,679,227
+63,688
+1% +$1.04M
MINI
18
DELISTED
Mobile Mini Inc
MINI
$103M 1.87%
2,378,496
-28,852
-1% -$1.2M
IPCM
19
DELISTED
IPC HEALTHCARE INC COM DTD
IPCM
$94.6M 1.71%
1,927,110
+43,011
+2% +$2.29M
PRLB icon
20
Protolabs
PRLB
$1.74B
$94.5M 1.71%
1,396,953
+41,768
+3% +$3.11M
ABCO
21
DELISTED
Advisory Board Co
ABCO
$90M 1.63%
1,400,785
+19,105
+1% +$1.21M
LLTC
22
DELISTED
Linear Technology Corp
LLTC
$88.6M 1.6%
1,820,275
+452,579
+33% +$20.9M
LKQ icon
23
LKQ Corp
LKQ
$6.75B
$87.7M 1.59%
3,328,127
+197,089
+6% +$5.51M
CCMP
24
DELISTED
CMC Materials, Inc. Common Stock
CCMP
$84.6M 1.53%
1,922,470
+15,504
+0.8% +$678K
SRCL
25
DELISTED
Stericycle Inc
SRCL
$84.5M 1.53%
743,310
+40,903
+6% +$4.73M

Similar funds

Riverbridge Partners's Q1 2014 Portfolio in Review

As of Q1 2014, Riverbridge Partners held 130 positions worth $5.53B, up 0.18% from $5.52B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Trading was light in Q1 2014: portfolio turnover was 4.6%. Riverbridge Partners opened 4 new positions and exited 2, leaving the 130-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 24% a quarter earlier, followed by Industrials and Healthcare.

  • Riverbridge Partners's largest Q1 2014 buy was Dorman Products: 699,282 shares worth $41.3M.
  • Riverbridge Partners added most to Linear Technology Corp in Q1 2014, an estimated $20.9M increase.
  • Riverbridge Partners's biggest Q1 2014 reduction was Athenahealth, Inc., cutting an estimated $65.4M.
  • Riverbridge Partners fully exited IBM in Q1 2014, selling an estimated $276K.
  • Riverbridge Partners's ten largest holdings make up 29% of its $5.53B portfolio in Q1 2014.
  • Riverbridge Partners opened 4 new positions and closed 2 in Q1 2014.
  • Riverbridge Partners's portfolio value rose 0.18% quarter-over-quarter to $5.53B.

Based on Riverbridge Partners's 13F filing for Q1 2014, filed 9 May 2014.